AAP
TECX

Arax Advisory Partners’s Tectonic Therapeutic TECX Stock Holding History

Arax Advisory Partners’s Portfolio TECX Stock Details TECX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-15
Closed -$235 – 4597
2025
Q3 		$235 Buy
+15
New +$310 ﹤0.01% 3435

Other funds holding TECX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

Arax Advisory Partners's TECX Position: Q4 2025 in Review

Arax Advisory Partners sold out of Tectonic Therapeutic (TECX) in Q4 2025, closing a stake of 15 shares — an estimated $235 sold.

Arax Advisory Partners first reported a position in TECX in Q3 2025 and held it in 1 quarter. The position peaked at $235 in Q3 2025. 105 funds tracked by Wall St. Rank hold TECX as of Q4 2025.

  • Arax Advisory Partners reported no remaining Tectonic Therapeutic position as of Q4 2025 after selling out during the quarter.
  • Arax Advisory Partners sold 15 Tectonic Therapeutic shares in Q4 2025, an estimated $235.
  • Arax Advisory Partners first reported a position in Tectonic Therapeutic in Q3 2025 and held it in 1 quarter.
  • Arax Advisory Partners's Tectonic Therapeutic position peaked at $235 in Q3 2025.
  • 105 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q4 2025.

Based on Arax Advisory Partners's 13F filing for Q4 2025, filed 13 Feb 2026.